Emerging biosensor technologies are enabling the measurement and analysis of valuable trace markers, leading to improved clinical outcomes by allowing the accurate observation of previously undetectable physiological signals in real time.

Biosensors Update

Healthcare is undergoing a sensing revolution; medical device manufacturers are improving diabetes outcomes using continuous glucose monitoring to measure, predict and manage blood glucose levels, and pharmaceutical companies are using wearable sensors to generate real-time healthcare efficacy data for clinical trials. The data produced can be analysed at an individual level to deliver tailored personalised therapies, and at a population level to identify trends and predict outcomes. These advantages are contingent on the ability to sense rich, accurate data. Biosensors provide this data, responding to the presence of a biological analyte and converting this response into a useful signal.

Biotechnology companies, pharmaceutical manufacturers, and sensor firms are all investing in research and development to eliminate time-consuming sample enrichment, move from discrete tests to real-time monitoring, advance non-invasive, minimally invasive, and implantable measurement techniques, and reduce the patient burden and sensing cost per-day.

TTP works with clients to design and develop innovative biosensors that enable the successful measurement of previously undetectable physiological signals.


The modelling phase is an area where TTP has excelled in producing unique applications to our problems. TTP engineers developed laboratory test beds that verified the modelling process and provided the ability to test theorized solutions without the need to do full-scale pilots. By narrowing down proposed solutions first by modelling and then on a test bed we could focus on a few key possibilities in our manufacturing environment, saving time and resources in this critical area.

Chuck Lynch

Senior Engineering Manager, Roche Diagnostics

Explore More industries

Life Science

We work at the intersection of physics, engineering and the biological sciences, creating and developing new technology for the life science industry.

Drug Delivery

Pharmaceutical companies face substantial challenges, from constraints in health spending to weakening drug pipelines. Yet opportunities exist for those bold enough to adapt, ranging from connected devices that drive adherence to generic devices at cost points previously thought impossible.

Medical Devices

Disruptive change is rolling through the medical device industry as value-based healthcare and digitisation spread from niches to the mainstream. This is a challenging time, but it presents real opportunities for those ambitious companies prepared to reinvent themselves.

In-vitro Diagnostics

The diagnostic market is at a moment of change. New approaches, such as sequencing, are gaining traction; companion diagnostics are driving closer integration with therapy; continuous monitoring is enabling new diagnostic information; and market drivers are demanding low cost distribution of clinical quality data.


Human therapies are adapting to tackle increasingly complex immunological diseases and conditions. These therapies often rely on tightly controlled cell cultures in order to produce therapeutic drugs efficiently, such as monoclonal antibodies or culture of the patient’s own genetically-engineered cells, as part of an autologous cell therapy workflow.

Smart Implants

Increasing numbers of people are suffering from chronic conditions. Through the creation of tiny, fully integrated real-time measurement systems, smart implants are bringing the benefits of laboratory-grade telemetry to their lives.

Digital Health

Healthcare consumers are no longer willing to accept a poor user experience, and the consumer world has set their expectations sky-high. We design products and health experiences encompassing both physical and digital products for the healthcare consumers of tomorrow.

Medical Imaging

Medical imaging is required to meet the needs of advanced diagnostics and the demands of emerging markets, presenting the sector with sizeable rewards for innovation.


Surgery is a fertile area for medical device innovation with remarkable developments occurring in minimally invasive and robotic assisted techniques. The future of the operating room relies on intraoperative technologies which improve clinical and economic values as measured by procedure outcome, workflow efficiency and patient safety.

Cell and Gene Therapy

Cell and Gene Therapies can cure the incurable. With more than a decade of experience, TTP works in partnership with companies to solve the challenges of these complex therapies. Together we will improve patient access and save lives.


Neurotechnology promises to revolutionise the treatment of a wide range of diseases. Improving outcomes for patients depends on bringing together an understanding of the pathology with the medical device hardware needed to physically interface with the nervous system.

Get in touch

We use cookies to improve your experience on our site. To find out more, read our updated privacy policy. More information.